FULLER & THALER ASSET MANAGEMENT, INC. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 178 filers reported holding HAEMONETICS CORP in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
FULLER & THALER ASSET MANAGEMENT, INC. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q4 2019$6,0000.0%490.0%0.00%
Q3 2019$6,000
-50.0%
49
-52.4%
0.00%
Q2 2019$12,000
+33.3%
1030.0%0.00%
Q1 2019$9,000
-57.1%
103
-50.7%
0.00%
Q4 2018$21,000
-100.0%
209
-100.0%
0.00%
-100.0%
Q3 2018$53,201,000
-19.3%
464,313
-36.9%
0.55%
-22.9%
Q2 2018$65,964,000
+20.3%
735,544
-1.9%
0.71%
+10.9%
Q1 2018$54,843,000
+25.7%
749,629
-0.2%
0.64%
+22.5%
Q4 2017$43,623,000
-46.9%
751,080
-58.9%
0.52%
-47.7%
Q3 2017$82,079,000
-6.4%
1,829,273
-17.6%
1.00%
-12.6%
Q2 2017$87,668,000
-2.2%
2,219,997
+0.5%
1.15%
-6.1%
Q1 2017$89,637,000
+8.1%
2,209,450
+7.1%
1.22%
-2.2%
Q4 2016$82,914,000
+8.1%
2,062,539
-2.6%
1.25%
-1.3%
Q3 2016$76,688,000
+23.9%
2,117,880
-0.8%
1.27%
+19.4%
Q2 2016$61,883,000
-2.9%
2,134,641
+17.1%
1.06%
-14.4%
Q1 2016$63,757,000
+38.2%
1,822,682
+27.4%
1.24%
+25.6%
Q4 2015$46,142,000
+30.7%
1,431,202
+31.0%
0.99%
+8.0%
Q3 2015$35,297,000
+12.6%
1,092,118
+44.1%
0.91%
+3.2%
Q2 2015$31,336,000
+14.2%
757,632
+24.1%
0.88%
+1.1%
Q1 2015$27,431,000
+44.2%
610,657
+20.2%
0.88%
+27.7%
Q4 2014$19,017,000
+25.2%
508,213
+16.9%
0.68%
+5.2%
Q3 2014$15,186,000
+16.8%
434,879
+18.0%
0.65%
+18.1%
Q2 2014$13,007,000368,6670.55%
Other shareholders
HAEMONETICS CORP shareholders Q2 2016
NameSharesValueWeighting ↓
LGT CAPITAL PARTNERS LTD. 1,216,059$64,500,0001.72%
HEARTLAND ADVISORS INC 406,192$21,544,0001.26%
KINGDON CAPITAL MANAGEMENT, L.L.C. 200,000$10,608,0001.22%
Aurora Investment Counsel 32,149$1,705,0001.01%
Endurant Capital Management LP 73,914$3,920,0000.95%
KINGDON CAPITAL MANAGEMENT, L.L.C. 135,000$7,160,0000.82%
ARMISTICE CAPITAL, LLC 872,000$46,251,0000.76%
Summit Creek Advisors LLC 131,357$6,967,0000.70%
Dean Capital Management 15,309$812,0000.70%
Keene & Associates, Inc. 11,720$622,0000.54%
View complete list of HAEMONETICS CORP shareholders